{"result": "(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic disease that affects how the body processes blood sugar (glucose) and is a significant health concern in Spain and worldwide.)\n##\n(\"entity\"<|>HIPERGLUCEMIA<|>EVENT<|>Hiper glucemia refers to high blood sugar levels, which is a common condition among diabetes patients and can lead to serious health complications.)\n##\n(\"entity\"<|>CASTILLA Y LEÓN<|>GEO<|>Castilla y León is a region in Spain known for its diabetes cohort study, CODICYL, which focuses on diabetes prevalence and management.)\n##\n(\"entity\"<|>ESTUDIO SECCAID<|>EVENT<|>Estudio SECCAID is a study that estimates the costs associated with diabetes and its complications in Spain.)\n##\n(\"entity\"<|>DIABETES MELLITUS DE CASTILLA Y LEÓN (CODICYL)<|>EVENT<|>CODICYL is a diabetes cohort study in the Castilla y León region that analyzes diabetes mortality and prevalence.)\n##\n(\"entity\"<|>NUEVA YORK<|>GEO<|>New York is a city in the United States that has been referenced in studies related to diabetes prevalence and hospitalizations.)\n##\n(\"relationship\"<|>DIABETES<|>HIPERGLUCEMIA<|>Hiper glucemia is a common complication of diabetes, indicating poor blood sugar control.<|>8)\n##\n(\"relationship\"<|>DIABETES MELLITUS DE CASTILLA Y LEÓN (CODICYL)<|>CASTILLA Y LEÓN<|>CODICYL is a study conducted in the Castilla y León region focusing on diabetes management and outcomes.<|>6)\n##\n(\"relationship\"<|>ESTUDIO SECCAID<|>DIABETES<|>Estudio SECCAID analyzes the costs associated with diabetes and its complications in Spain.<|>7)\n##\n(\"relationship\"<|>NUEVA YORK<|>DIABETES<|>New York has been involved in various studies and statistics related to diabetes prevalence and management.<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: fermedad-cardiovascular.\n    Acceso 6 de octubre de 2018.\n\n\n\n    6. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio, Gao P, Sarwar, et al. Diabetes\n    mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011 Mar 3;364(9):829-841.\n    doi: 10.1056/NEJMoa1008862.\n\n\n\n    7. Orozco-Beltrán D, et al. Evolucio´n de la mortalidad por diabetes mellitus en Espan˜a: análisis del\n    periodo 1998-2013. Rev Esp Cardiol. 2016. http://dx.doi.org/10.1016/j.recesp.2016.07.007\n\n\n\n    8. Cohorte de Diabetes Mellitus de Castilla y León (CODICYL). En: https://www.saludcastillayleon.es/\n    profesionales/es/cardiovascular/cohorte-diabetes. Acceso 6 de octubre de 2018.\n\n\n\n    9. Federación Española de Diabetes (FEDE). Infografías. En: https://www.fedesp.es/bddocumentos/1/\n    La-diabetes-en-espa%C3%B1a-infografia_def.pdf Acceso 6 de octubre de 2018.\n\n\n\n    10. Crespo C, Brosa M, Soria-Juan A, Lopez-Alba A, Lopez-Martínez N, Soria B. Costes directos de la\n    diabetes mellitus y de sus complicaciones en España. (Estudio SECCAID: Spain estimated cost\n    Ciberdem-Cabimer in Diabetes). Av Diabetol. 2013;29(6):182-189.\n\n\n\n24\n---\n  Artículos Especiales\nNutrición y diabetes                                mellitus\nDr. Alejandro Sanz París y Dr. Francisco Losfablos Callau\nUnidad de Nutrición y Dietética.\nHospital Universitario Miguel Servet de Zaragoza.\n\n\n\n         La hiperglucemia es una situación de alta frecuencia tanto en el área hospitala-\nria como entre las personas que viven en su domicilio. En España, los últimos estudios\nmuestran que el 14% de la población es diabética1 y en una revisión de 126 hospitales\nnorteamericanos el 31.7% de los pacientes fuera de la UCI presentaban glucemia mayor\nde 180 mg/dl2 .\n         Según datos emitidos por la OMS 3 se estima que existen aproximadamente 422\nmillones de personas con diabetes en el mundo. Su prevalencia en adultos mayores de\n18 años en el año de 2014 fue del 9%, y en 2012 fallecieron 1,5 millones de personas\ncomo consecuencia directa de esta enfermedad siendo más del 80% de las muertes por\ndiabetes registradas en países de ingresos bajos y medios. Según sus proyecciones, la\ndiabetes será la séptima causa de mortalidad en 2030, la gran mayoría de ellos DM2, y\nes a día de hoy una de las principales causas de ceguera, fallo renal, ataque al corazón,\naccidente cerebrovascular y amputaciones de los miembros inferiores. Este importante\nincremento se atribuye sobre todo al crecimiento y el envejecimiento de la población,\nla mayor frecuencia de obesidad, la falta de ejercicio y la urbanización.\n\n\n\n         En pacientes hospitalizados en España 4 , la prevalencia de diabetes se ha esti-\nmado en un 17,8%, y notablemente más alta en aquellos ingresos mayores de 65 años\nde edad, 39,9%. En cuanto a la población hospitalizada5 , la aparición de hiperglucemia\npor diversas patologías puede ser del 21,5%. Aquellos pacientes con valores más eleva-\ndos de hemoglobina glicosilada (HbA1C) presentan riesgos más elevados de ingreso6 .\n         Además de esta hiperglucemia crónica por DM, podemos encontrarnos en la\npráctica clínica con la llamada “hiperglucemia de estrés”, que aparece en paciente\ncrítico u hospitalizado por enfermedad no crítica sin antecedentes de DM, pero con\nglucemias persistentes mayores de 126 mg/dl en ayunas o de 200 mg/dl en cualquier\nmomento del día. Su prevalencia oscila entre el 4-12% de los pacientes hospitalizados\nsin diabetes conocida. Llega a ser de más del 30% en los pacientes con nutrición\nenteral7 y del 35% en parenteral, aunque depende mucho de los criterios de definición\nempleados8 .\n                                                                                           25\n---\n    Coste sanitario y Diabetes\n             La presencia de hiperglucemia se asocia a una peor evolución intrahospitalaria\n    y por tanto a estancia hospitalaria más larga y mayores costes sanitarios. Se ha calcu-\n    lado que por cada 18 mg/dl más de la cifra normal de glucemia al ingreso hospitalario,\n    aumenta un 5% el riesgo de complicaciones y un 8% la mortalidad9 . En\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HOSPITAL UNIVERSITARIO MIGUEL SERVET<|>ORGANIZATION<|>Hospital Universitario Miguel Servet de Zaragoza is a medical institution involved in diabetes care and research.)\n##\n(\"entity\"<|>FEDERACIÓN ESPAÑOLA DE DIABETES<|>ORGANIZATION<|>Federación Española de Diabetes (FEDE) is an organization that provides information and resources related to diabetes in Spain.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes mellitus is a chronic health condition characterized by high blood sugar levels, which has significant health implications.)\n##\n(\"entity\"<|>OMS<|>ORGANIZATION<|>The World Health Organization (OMS) is a specialized agency of the United Nations responsible for international public health.)\n##\n(\"entity\"<|>ZARAGOZA<|>GEO<|>Zaragoza is a city in Spain where the Hospital Universitario Miguel Servet is located.)\n##\n(\"entity\"<|>CASTILLA Y LEÓN<|>GEO<|>Castilla y León is a region in Spain known for its diabetes cohort study, CODICYL.)\n##\n(\"entity\"<|>CIBERDEM-CABIMER<|>ORGANIZATION<|>Ciberdem-Cabimer is a research network focused on diabetes in Spain.)\n##\n(\"entity\"<|>ALEJANDRO SANZ PARÍS<|>PERSON<|>Dr. Alejandro Sanz París is a medical professional involved in diabetes research and treatment.)\n##\n(\"entity\"<|>FRANCISCO LOSFABLOS CALLAU<|>PERSON<|>Dr. Francisco Losfablos Callau is a medical professional working in the field of nutrition and diabetes.)\n##\n(\"relationship\"<|>HOSPITAL UNIVERSITARIO MIGUEL SERVET<|>FEDERACIÓN ESPAÑOLA DE DIABETES<|>The Hospital Universitario Miguel Servet collaborates with the Federación Española de Diabetes to provide diabetes care and resources.<|>7)\n##\n(\"relationship\"<|>HOSPITAL UNIVERSITARIO MIGUEL SERVET<|>DIABETES MELLITUS<|>The Hospital Universitario Miguel Servet treats patients with diabetes mellitus and conducts related research.<|>8)\n##\n(\"relationship\"<|>OMS<|>DIABETES MELLITUS<|>The World Health Organization provides global health guidelines and statistics related to diabetes mellitus.<|>6)\n##\n(\"relationship\"<|>CASTILLA Y LEÓN<|>CIBERDEM-CABIMER<|>The Ciberdem-Cabimer research network conducts studies on diabetes in the Castilla y León region.<|>5)\n##\n(\"relationship\"<|>ALEJANDRO SANZ PARÍS<|>HOSPITAL UNIVERSITARIO MIGUEL SERVET<|>Dr. Alejandro Sanz París works at the Hospital Universitario Miguel Servet, focusing on diabetes treatment.<|>9)\n##\n(\"relationship\"<|>FRANCISCO LOSFABLOS CALLAU<|>HOSPITAL UNIVERSITARIO MIGUEL SERVET<|>Dr. Francisco Losfablos Callau is associated with the Hospital Universitario Miguel Servet, specializing in nutrition and diabetes.<|>9)\n<|COMPLETE|>"}]}